Young Richard A

Young Richard A is listed in filings as Director at CAMP4 Therapeutics Corporation. This profile follows SEC Form 4 activity through Sep 11, 2025, including purchase activity and sale activity. Recent filings connect the profile to CAMP4 Therapeutics Corporation (CAMP), Syros Pharmaceuticals, Inc. (SYRS), and Omega Therapeutics, Inc. (OMGA). The current snapshot covers public activity from Jun 21, 2024 to Sep 11, 2025. Reported amounts are shown as $25.0K to $178.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.